Barkouky Electric

Barkouky Electric company information, Employees & Contact Information

Barkouky Electric (BE) was founded in 1977 and specializes in Turn-key Electro-Mechanical Contracting that includes all solutions starting from the MV side down to the electrical wiring devices. Since day one and till our present time, we are in alert position to keep our high quality standards by only working with products totally manufactured by our partners therefore guaranteeing that all products are Design Verified (totally type-tested) and have passed all routine tests by the best known North American and European testing facilities. Our license agreements with our partners ( Eaton and its subsidiaries ) which states that we are system integrators, gives us the right to integrate our partner’s wide range of solutions to grant our customers a complete solution. We do our best to apply our expertise to exceed customer expectations.

Company Details

Employees
23
Founded
-
Address
49 Shaheed Sayed Zakaria Street Sheraton Heliopolis Housing,cairo,egypt, Cairo,egypt
Industry
Appliances, Electrical, And Electronics Manufacturing
NAICS
Electrical Equipment, Appliance, and Component Manufacturing
Other Electrical Equipment and Component Manufacturing
Battery Manufacturing
Communication and Energy Wire and Cable Manufacturing
Wiring Device Manufacturing
All Other Electrical Equipment and Component Manufacturing
Storage Battery Manufacturing
Primary Battery Manufacturing
Fiber Optic Cable Manufacturing
Other Communication and Energy Wire Manufacturing
Current-Carrying Wiring Device Manufacturing
Noncurrent-Carrying Wiring Device Manufacturing
Carbon and Graphite Product Manufacturing
All Other Miscellaneous Electrical Equipment and Component Manufacturing
HQ
Cairo
Looking for a particular Barkouky Electric employee's phone or email?

Barkouky Electric Questions

News

Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ... - Yahoo Finance

Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ... Yahoo Finance

Oct 29: Emergent BioSolutions to Report Q3 Results; Webcast and Call Registration Details - Stock Titan

Oct 29: Emergent BioSolutions to Report Q3 Results; Webcast and Call Registration Details Stock Titan

Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way? - simplywall.st

Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way? simplywall.st

Earnings call transcript: Emergent BioSolutions Q1 2025 sees 656% net income rise - Investing.com

Earnings call transcript: Emergent BioSolutions Q1 2025 sees 656% net income rise Investing.com

Emergent BioSolutions Inc. SEC 10-Q Report - TradingView

Emergent BioSolutions Inc. SEC 10-Q Report TradingView

Contact BioSolutions to unveil eco-friendly herbicide at Homestead Conference - Landscape Management

Contact BioSolutions to unveil eco-friendly herbicide at Homestead Conference Landscape Management

Emergent BioSolutions Reports Second Quarter 2025 Financial Results - The Manila Times

Emergent BioSolutions Reports Second Quarter 2025 Financial Results The Manila Times

$29M Defense Order: Emergent BioSolutions Expands Global MCM Supply as NATO Defense Spending Rises - Stock Titan

$29M Defense Order: Emergent BioSolutions Expands Global MCM Supply as NATO Defense Spending Rises Stock Titan

Emergent BioSolutions Launches College Naloxone Education Campaign | EBS Stock News - Stock Titan

Emergent BioSolutions Launches College Naloxone Education Campaign | EBS Stock News Stock Titan

Emergent BioSolutions Inc (EBS) Quarterly 10-Q Report - qz.com

Emergent BioSolutions Inc (EBS) Quarterly 10-Q Report qz.com

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful - Seeking Alpha

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful Seeking Alpha

$17M Contract: Emergent BioSolutions Expands Critical Smallpox Treatment Supply for U.S. Defense - Stock Titan

$17M Contract: Emergent BioSolutions Expands Critical Smallpox Treatment Supply for U.S. Defense Stock Titan

45% of Retail Workers Have Witnessed Naloxone Use: Emergent BioSolutions Tackles Workplace Opioid Crisis - Stock Titan

45% of Retail Workers Have Witnessed Naloxone Use: Emergent BioSolutions Tackles Workplace Opioid Crisis Stock Titan

Biotech Leader Emergent BioSolutions Announces Double-Header Healthcare Conference Schedule for September - Stock Titan

Biotech Leader Emergent BioSolutions Announces Double-Header Healthcare Conference Schedule for September Stock Titan

$120M Total Sales: Emergent's Smallpox Vaccine ACAM2000 Scores New $56M U.S. Government Contract - Stock Titan

$120M Total Sales: Emergent's Smallpox Vaccine ACAM2000 Scores New $56M U.S. Government Contract Stock Titan

70% of Overdose Deaths Linked to Fentanyl: Emergent BioSolutions Launches Times Square Campaign - Stock Titan

70% of Overdose Deaths Linked to Fentanyl: Emergent BioSolutions Launches Times Square Campaign Stock Titan

Emergent BioSolutions Achieves Major Milestone: Russell 3000 Index Addition Signals Growth Phase - Stock Titan

Emergent BioSolutions Achieves Major Milestone: Russell 3000 Index Addition Signals Growth Phase Stock Titan

$30M Government Contract: Emergent BioSolutions to Supply Critical Two-Dose Anthrax Defense Vaccine - Stock Titan

$30M Government Contract: Emergent BioSolutions to Supply Critical Two-Dose Anthrax Defense Vaccine Stock Titan

Emergent BioSolutions Lines Up 4 Major Wall Street Conferences: RBC, Goldman Sachs, Jefferies Featured - Stock Titan

Emergent BioSolutions Lines Up 4 Major Wall Street Conferences: RBC, Goldman Sachs, Jefferies Featured Stock Titan

$62.4M Government Contract: Emergent BioSolutions to Supply Critical Botulism Treatment to US Stockpile - Stock Titan

$62.4M Government Contract: Emergent BioSolutions to Supply Critical Botulism Treatment to US Stockpile Stock Titan

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally - Seeking Alpha

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally Seeking Alpha

Emergent BioSolutions Strengthens US Biodefense Arsenal with $51.9M Government Contract - Stock Titan

Emergent BioSolutions Strengthens US Biodefense Arsenal with $51.9M Government Contract Stock Titan

Emergent BioSolutions Expands Global Reach with $27M Medical Defense Deal - Stock Titan

Emergent BioSolutions Expands Global Reach with $27M Medical Defense Deal Stock Titan

Biosolutions to Give you an Edge - ADM

Biosolutions to Give you an Edge ADM

Just Awarded: Emergent BioSolutions Grants Major 72,882 Share Package to Strategic New Hire - Stock Titan

Just Awarded: Emergent BioSolutions Grants Major 72,882 Share Package to Strategic New Hire Stock Titan

Alfa Laval announces new transatlantic biosolutions initiative - Sustainability Online

Alfa Laval announces new transatlantic biosolutions initiative Sustainability Online

Save The Date: Emergent BioSolutions Q1 2025 Earnings Conference Call Coming May 7 - Stock Titan

Save The Date: Emergent BioSolutions Q1 2025 Earnings Conference Call Coming May 7 Stock Titan

Joseph Papa, after leaving Bausch, begins another turnaround project as CEO of Emergent BioSolutions - Fierce Pharma

Joseph Papa, after leaving Bausch, begins another turnaround project as CEO of Emergent BioSolutions Fierce Pharma

Emergent BioSolutions Settles Stockholders Class Action for $40 Million - Claim Depot

Emergent BioSolutions Settles Stockholders Class Action for $40 Million Claim Depot

Breaking: Dramatic 34% Drop in US Opioid Deaths as Emergent Expands Life-Saving Naloxone Access - Stock Titan

Breaking: Dramatic 34% Drop in US Opioid Deaths as Emergent Expands Life-Saving Naloxone Access Stock Titan

Emergent BioSolutions: Stock Is A Likely Winner In 2025 (NYSE:EBS) - Seeking Alpha

Emergent BioSolutions: Stock Is A Likely Winner In 2025 (NYSE:EBS) Seeking Alpha

Emergent BioSolutions Outpaces Its Own Forecasts But Misses Analyst Targets - Finimize

Emergent BioSolutions Outpaces Its Own Forecasts But Misses Analyst Targets Finimize

Emergent BioSolutions Lands Major $65M Deal: Ontario Chooses NARCAN to Fight Opioid Crisis - Stock Titan

Emergent BioSolutions Lands Major $65M Deal: Ontario Chooses NARCAN to Fight Opioid Crisis Stock Titan

$500K Milestone Achieved: Dyadic Applied BioSolutions Advances Commercial Launches, $250K Inzymes - Stock Titan

$500K Milestone Achieved: Dyadic Applied BioSolutions Advances Commercial Launches, $250K Inzymes Stock Titan

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine - CEPI

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine CEPI

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain - The Manila Times

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain The Manila Times

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 - The Manila Times

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 The Manila Times

How One Firm Put an ‘Extraordinary Burden’ on the U.S.’s Troubled Stockpile (Published 2021) - The New York Times

How One Firm Put an ‘Extraordinary Burden’ on the U.S.’s Troubled Stockpile (Published 2021) The New York Times

TradeShow Talks with GNA Biosolutions - News-Medical

TradeShow Talks with GNA Biosolutions News-Medical

Why Emergent BioSolutions Slipped on Friday - The Motley Fool

Why Emergent BioSolutions Slipped on Friday The Motley Fool

EBS - Emergent Biosolutions Inc Latest Stock News & Market Updates - Stock Titan

EBS - Emergent Biosolutions Inc Latest Stock News & Market Updates Stock Titan

Sustainable Biosolutions registers revenue of over Rs 3 crore in FY23 - CNBC TV18

Sustainable Biosolutions registers revenue of over Rs 3 crore in FY23 CNBC TV18

EBS Stock Price and Chart — NYSE:EBS - TradingView

EBS Stock Price and Chart — NYSE:EBS TradingView

24,400 Shares in Emergent Biosolutions Inc. $EBS Purchased by Stratos Wealth Partners LTD. - Defense World

24,400 Shares in Emergent Biosolutions Inc. $EBS Purchased by Stratos Wealth Partners LTD. Defense World

Emergent Biosolutions (NYSE:EBS) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Emergent Biosolutions (NYSE:EBS) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? Defense World

Allianz Asset Management GmbH Purchases New Stake in Emergent Biosolutions Inc. $EBS - Defense World

Allianz Asset Management GmbH Purchases New Stake in Emergent Biosolutions Inc. $EBS Defense World

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant